Hide metadata

dc.date.accessioned2024-03-01T18:12:11Z
dc.date.available2024-03-01T18:12:11Z
dc.date.created2024-01-04T11:41:37Z
dc.date.issued2023
dc.identifier.citationVaage, Anders Myhre Saltyte Benth, Jurate Meyer, Haakon Eduard Holmøy, Trygve Nakken, Ola . Premorbid lipid levels and long-term risk of ALS—a population-based cohort study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2023
dc.identifier.urihttp://hdl.handle.net/10852/108869
dc.description.abstractObjective To assess the temporal relationship between premorbid lipid levels and long-term amyotrophic lateral sclerosis (ALS) risk. Methods From Norwegian cardiovascular health surveys (1974–2003), we collected information on total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), glucose, and other cardiovascular risk factors. ALS incidence and mortality were identified through validated Norwegian health registries. The relation between premorbid lipid levels and ALS risk was assessed by Cox regression models. Results Out of 640,066 study participants (51.5% females), 974 individuals (43.5% females) developed ALS. Mean follow-up time was 23.7 (SD 7.1) years among ALS cases. One mmol/l increase in LDL-C was associated with 6% increase in risk for ALS (hazard ratio 1.06 [95% CI: 1.01–1.09]). Higher levels of TC and TG were also associated with increased ALS risk, but only within the last 6–7 years prior to ALS diagnosis or death. No association between HDL-C and ALS risk was found. Adjusting for body mass index, birth cohort, smoking, and physical activity did not alter the results. Conclusions Higher levels of LDL-C are associated with increased ALS risk over 40 years later, compatible with a causal relationship. The temporal relationship between TG, TC, and ALS risk suggests that increased levels of these lipid biomarkers represent consequences of ALS.
dc.languageEN
dc.publisherInforma healthcare
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titlePremorbid lipid levels and long-term risk of ALS—a population-based cohort study
dc.title.alternativeENEngelskEnglishPremorbid lipid levels and long-term risk of ALS—a population-based cohort study
dc.typeJournal article
dc.creator.authorVaage, Anders Myhre
dc.creator.authorSaltyte Benth, Jurate
dc.creator.authorMeyer, Haakon Eduard
dc.creator.authorHolmøy, Trygve
dc.creator.authorNakken, Ola
cristin.unitcode185,53,82,0
cristin.unitnameKlinikk for indremedisin og lab fag
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin2220541
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration&rft.volume=&rft.spage=&rft.date=2023
dc.identifier.jtitleAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration
dc.identifier.startpage1
dc.identifier.endpage9
dc.identifier.doihttps://doi.org/10.1080/21678421.2023.2295455
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2167-8421
dc.type.versionPublishedVersion
dc.relation.projectHSØ/2022050
dc.relation.projectALSNORGE/-


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International